[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346527-105":59,"doc-detail-346527-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","systematic-annotation-of-orphan-rnas-reveals-blood-accessible-molecular-barcodes-of-cancer-identity-and-cancer-emergent-oncogenic-drivers","Systematic annotation of orphan RNAs reveals blood-accessible molecular barcodes of cancer identity and cancer-emergent oncogenic drivers","","Wang and colleagues systematically annotate orphan non-coding RNAs (oncRNAs) across 32 tumor types, identifying a large repertoire of cancer-emergent small RNAs that form digital presence-absence patterns. These binary patterns function as molecular barcodes that capture cancer type and subtype identities. A subset of oncRNAs is partially accessible from cell-free space, reflecting secretion by cancer cells. Large-scale in vivo genetic screens in xenografted mice reveal driver oncRNAs that promote tumor progression. In a retrospective cohort of 192 breast cancer patients, circulating oncRNAs are detectable in blood and their changes predict short- and long-term clinical outcomes, supporting liquid biopsy utility for minimum residual disease monitoring.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/systematic-annotation-of-orphan-rnas-reveals-blood-accessible-molecular-barcodes-of-cancer-identity-and-cancer-emergent-oncogenic-drivers/346527/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/systematic-annotation-of-orphan-rnas-reveals-blood-accessible-molecular-barcodes-of-cancer-identity-and-cancer-emergent-oncogenic-drivers/346527.png","ImageObject",300,407,{"name":92,"@type":93},"Finn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What are orphan non-coding RNAs (oncRNAs) in this study?","Question",{"text":112,"@type":113},"The study focuses on orphan oncRNAs, a class of cancer-emergent small RNAs expressed in cancer cells but absent in non-transformed tissue.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do oncRNAs help distinguish cancer types and subtypes?",{"text":117,"@type":113},"OncRNA presence-absence patterns create digital molecular barcodes that reliably discriminate between cancer types and subtypes.",{"name":119,"@type":110,"acceptedAnswer":120},"How can circulating oncRNAs be used clinically?",{"text":121,"@type":113},"The paper reports that circulating oncRNAs are detectable in blood and that changes in oncRNA burden predict short-term and long-term clinical outcomes in breast cancer patients, supporting liquid biopsy applications for minimum residual disease monitoring.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},346527,1791080845,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","Article  \nSystematic annotation of orphan RNAs reveals blood-accessible molecular barcodes of cancer identity and cancer-emergent oncogenic drivers  \nAuthors  \nJeffrey Wang, Jung Min Suh,  \nBrian J. Woo, ..., Laura J. Esserman, Laura J. van ‘t Veer, Hani Goodarzi  \nCorrespondence  \n[hani.goodarzi@ucsf.edu](hani.goodarzi@ucsf.edu)  \nIn brief  \nWang et al. systematically annotate orphan non-coding RNAs (oncRNAs), cancer-emergent small RNAs, across 32 cancers. The study demonstrates that oncRNAs are informative of cancer types and have functional roles in cancer progression. Importantly, circulating oncRNAs are predictive of clinical outcomes in breast cancer patients, holding potential for liquid biopsy applications.  \n• OncRNAs patterns are molecular barcodes capable of distinguishing cancer types and subtypes  \n• Using large-scale genetic screens, we find some oncRNAs drive cancer progression  \n• Circulating oncRNAs are predictive of clinical outcomes in breast cancer patients  \nWang et al., 2026, Cell Reports Medicine 7, 102577  \nFebruary 17, 2026 © 2025 The Author(s) . Published by Elsevier Inc.  \n[https://doi.org/10.1016/j.xcrm.2025.102577](https://doi.org/10.1016/j.xcrm.2025.102577)  \nll  \nll  \nOPEN ACCESS  \nArticle  \nSystematic annotation of orphan RNAs reveals blood-accessible molecular barcodes of cancer identity and cancer-emergent oncogenic drivers  \nJeffrey Wang,1,2,3,4,9,11 Jung Min Suh,1,2,3,4,11 Brian J. Woo,1,2,3,4,11 Albertas Navickas,1,2,3,4,10,11 Kristle Garcia,1,2,3,4 Keyi Yin,1,2,3,4 Lisa Fish,1,2,3,4 Taylor Cavazos,5 Benjamin H¨anisch,1,2,3,4 Daniel Markett,1,2,3,4 Gillian L. Hirst,6 Lamorna Brown-Swigart,7 Laura J. Esserman,6 Laura J. van ‘t Veer,7 and Hani Goodarzi1,2,3,4,8,12,*  \n1Department of Biochemistry & Biophysics, University of California, San Francisco, San Francisco, CA, USA  \n2Department of Urology, University of California, San Francisco, San Francisco, CA, USA  \n3Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA  \n4Bakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA, USA  \n5Biological and Medical Informatics, University of California, San Francisco, San Francisco, CA 94158, USA  \n6Department of Surgery, University of California, San Francisco, San Francisco, CA 94143, USA  \n7Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA 94143, USA  \n8Arc Institute, Palo Alto, CA 94304, USA  \n9Present address: School of Medicine, University of California, Davis, Davis, CA, USA  \n10Present address: Institut Curie, CNRS UMR3348, INSERM U1278, Orsay, France  \n11These authors contributed equally  \n12Lead contact  \n*Correspondence: [hani.goodarzi@ucsf.edu](hani.goodarzi@ucsf.edu)[ ](hani.goodarzi@ucsf.edu)[https://doi.org/10.1016/j.xcrm.2025.102577](https://doi.org/10.1016/j.xcrm.2025.102577)  \nSUMMARY  \nFrom extrachromosomal DNA to neo-peptides, reprogramming of cancer genomes leads to the emergence of cancer state-specific molecules. Here, we systematically identify and characterize a large repertoire of orphan non-coding RNAs (oncRNAs), a class of cancer-emergent small RNAs, across 32 tumor types. We show that oncRNA binary presence-absence patterns represent a digital molecular barcode that captures cancer type and subtype identities. Importantly, this barcode is partially accessible from the cell-free space as cancer cells secrete a subset of oncRNAs. Leveraging large-scale in vivo genetic screens in xenografted mice, we functionally identify driver oncRNAs in multiple tumor types. In a retrospective study across 192 breast cancer patients, we show that oncRNAs are reliably detected in blood and that changes in cell-free oncRNA burden predict both short-term and long-term clinical outcomes. Together, we establish that oncRNAs have potential roles in tumor progression and clinical utility in liquid biopsies for tumor-naive minimum residual disease m","cbCaieTznU6q6lpq","https://ap.wps.com/l/cbCaieTznU6q6lpq","pdf",11712017,25,"English","# Summary\n# Introduction\n## Cancer-emergent molecules and prior oncRNA findings\n## Goals and overall approach\n# Results and clinical relevance\n## OncRNA barcode patterns across 32 tumor types\n## Xenograft genetic screens to find driver oncRNAs\n## Blood-based detection and outcome prediction in breast cancer","[{\"question\":\"What are orphan non-coding RNAs (oncRNAs) in this study?\",\"answer\":\"The study focuses on orphan oncRNAs, a class of cancer-emergent small RNAs expressed in cancer cells but absent in non-transformed tissue.\"},{\"question\":\"How do oncRNAs help distinguish cancer types and subtypes?\",\"answer\":\"OncRNA presence-absence patterns create digital molecular barcodes that reliably discriminate between cancer types and subtypes.\"},{\"question\":\"How can circulating oncRNAs be used clinically?\",\"answer\":\"The paper reports that circulating oncRNAs are detectable in blood and that changes in oncRNA burden predict short-term and long-term clinical outcomes in breast cancer patients, supporting liquid biopsy applications for minimum residual disease monitoring.\"}]","Systematic annotation of orphan RNAs reveals blood-accessible molecular barcodes of cancer identity and cancer-emergent oncogenic drivers | PDF",1790061834,63,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/26e9ffafd448b928d397fcd89ccf17d5.webp",983,1276,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/32fd291bf7491faec876bd7eee4803ac.webp",982,1275,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/28ecc33a2e045d4530bf6144c3a300e9.webp",981,1273,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a316fd97aafa81809f0e52a6ed14226b.webp",980,1272]